Lv41
700 积分 2022-05-29 加入
10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population
7小时前
待确认
Implementation of a liver health check in people with type 2 diabetes
9小时前
待确认
Implementation of a liver health check in people with type 2 diabetes
13小时前
待确认
Metabolic Dysfunction-Associated Steatotic Liver Disease and the Cardiovascular System
5天前
已完结
The cellular and molecular mechanisms mediating the protective effects of sodium–glucose linked transporter 2 inhibitors against metabolic dysfunction‐associated fatty liver disease
5天前
已完结
Metabolic‐associated fatty liver disease in relation to site‐specific and multiple‐site subclinical atherosclerosis
5天前
已完结
AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk : Insights From MESA and the UK Biobank
9天前
已完结
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
10天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
11天前
已完结
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
11天前
已完结
皖公网安备34019202002308
